Hochschulschrift
Präklinische Verwendung verschiedener onkolytischer Vaccinia-Viren zur Therapie von Human- und Hundetumoren
- Alternative title
-
Preclinical application of different oncolytic vaccinia viruses in human and canine tumor therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Würzburg, Universität Würzburg, Dissertation, 2012
- Keyword
-
Vaccinia-Virus
Tumor
Therapie
Onkolyse
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2014
- Creator
- Contributor
-
Szalay, Aladár
- URN
-
urn:nbn:de:bvb:20-opus-70688
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Adelfinger, Marion
- Szalay, Aladár
- Universität Würzburg
Time of origin
- 2014
Other Objects (12)
Präklinische Verwendung onkolytischer Vaccinia-Viren zur Therapie von Human- und Hundetumoren
Biochemische und strukturelle Charakterisierung der Genexpressionsmaschinerie des Vaccinia Virus
Functional Characterization of Vaccinia Virus Gene Expression Machinery
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Use of Tumor Vasculature for Successful Treatment of Carcinomas by Oncolytic Vaccinia Virus
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Immunotherapy with Vaccinia virus co-expressing tumor-associated antigens and mouse IL-2 cytokine in mice with mammary cancer
Vaccinia Virus-mediated Therapy of Solid Tumor Xenografts: Intra-tumoral Delivery of Therapeutic Antibodies
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Cellular Factors Contributing to Host Cell Permissiveness in Support of Oncolytic Vaccinia Virus Replication
Melanogene rekombinante Vaccinia-Viren als diagnostisches und therapeutisches Agenz zur Tumorbehandlung
Präklinische Verwendung onkolytischer Vaccinia-Viren zur Therapie von Human- und Hundetumoren
Biochemische und strukturelle Charakterisierung der Genexpressionsmaschinerie des Vaccinia Virus
Functional Characterization of Vaccinia Virus Gene Expression Machinery
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Use of Tumor Vasculature for Successful Treatment of Carcinomas by Oncolytic Vaccinia Virus
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Immunotherapy with Vaccinia virus co-expressing tumor-associated antigens and mouse IL-2 cytokine in mice with mammary cancer
Vaccinia Virus-mediated Therapy of Solid Tumor Xenografts: Intra-tumoral Delivery of Therapeutic Antibodies
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Cellular Factors Contributing to Host Cell Permissiveness in Support of Oncolytic Vaccinia Virus Replication
Melanogene rekombinante Vaccinia-Viren als diagnostisches und therapeutisches Agenz zur Tumorbehandlung
Präklinische Verwendung onkolytischer Vaccinia-Viren zur Therapie von Human- und Hundetumoren
Biochemische und strukturelle Charakterisierung der Genexpressionsmaschinerie des Vaccinia Virus
Functional Characterization of Vaccinia Virus Gene Expression Machinery
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Use of Tumor Vasculature for Successful Treatment of Carcinomas by Oncolytic Vaccinia Virus
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Immunotherapy with Vaccinia virus co-expressing tumor-associated antigens and mouse IL-2 cytokine in mice with mammary cancer
Vaccinia Virus-mediated Therapy of Solid Tumor Xenografts: Intra-tumoral Delivery of Therapeutic Antibodies
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Cellular Factors Contributing to Host Cell Permissiveness in Support of Oncolytic Vaccinia Virus Replication